ATE145246T1 - Monoklonale antikörper zur induzierung von toleranz - Google Patents

Monoklonale antikörper zur induzierung von toleranz

Info

Publication number
ATE145246T1
ATE145246T1 AT90908270T AT90908270T ATE145246T1 AT E145246 T1 ATE145246 T1 AT E145246T1 AT 90908270 T AT90908270 T AT 90908270T AT 90908270 T AT90908270 T AT 90908270T AT E145246 T1 ATE145246 T1 AT E145246T1
Authority
AT
Austria
Prior art keywords
depleting
monoclonal antibodies
inducing tolerance
monoclonal antibody
tolerance
Prior art date
Application number
AT90908270T
Other languages
English (en)
Inventor
Stephen Paul Cobbold
Herman Waldmann
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE145246T1 publication Critical patent/ATE145246T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90908270T 1989-05-31 1990-05-31 Monoklonale antikörper zur induzierung von toleranz ATE145246T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898912497A GB8912497D0 (en) 1989-05-31 1989-05-31 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
ATE145246T1 true ATE145246T1 (de) 1996-11-15

Family

ID=10657649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908270T ATE145246T1 (de) 1989-05-31 1990-05-31 Monoklonale antikörper zur induzierung von toleranz

Country Status (19)

Country Link
EP (1) EP0474691B1 (de)
JP (1) JP2763197B2 (de)
KR (1) KR0183029B1 (de)
AT (1) ATE145246T1 (de)
AU (1) AU657255B2 (de)
CA (1) CA2055615C (de)
DD (1) DD296843A5 (de)
DE (1) DE69029134T2 (de)
DK (1) DK0474691T3 (de)
ES (1) ES2096588T3 (de)
GB (1) GB8912497D0 (de)
HU (1) HUT61341A (de)
IE (1) IE80735B1 (de)
IL (1) IL94566A0 (de)
MY (1) MY135673A (de)
NZ (1) NZ233889A (de)
PT (1) PT94214B (de)
WO (1) WO1990015152A1 (de)
ZA (1) ZA904174B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100741D0 (en) * 1991-01-14 1991-02-27 Univ London Treatment of disease
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
AU687755B2 (en) * 1992-08-21 1998-03-05 Genentech Inc. Method for treating an LFA-1-mediated disorder
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
CA2221350A1 (en) * 1995-05-18 1996-11-21 Ortho Pharmaceutical Corporation Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
EP1212422B1 (de) 1999-08-24 2007-02-21 Medarex, Inc. Humane antikörper gegen ctla-4 und deren verwendungen
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
JP4764590B2 (ja) 2000-04-29 2011-09-07 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 黄班変性関連疾患の診断および治療
EP1395284B1 (de) * 2001-06-14 2010-12-08 Isis Innovation Limited Nicht-depletierender Antikörper TRX-1 gegen CD4 und dessen Verwendungen
US7541443B2 (en) 2001-06-14 2009-06-02 Tolerrx, Inc. Anti-CD4 antibodies
EP1460088A1 (de) 2003-03-21 2004-09-22 Biotest AG Humanisierter Antikörper gegen CD4 mit immunsuppressiven Merkmalen
GB0314461D0 (en) * 2003-06-20 2003-07-23 Isis Innovation Suppression of transplant rejection
CA2570849A1 (en) * 2004-06-22 2006-01-05 Tolerrx, Inc. Optimized dosing with anti-cd4 antibodies for tolerance induction in primates
EP2260057B1 (de) 2008-03-13 2016-11-23 Biotest AG Anti-CD4 Antikörper Dosierungsschema zur Behandlung von Autoimmunkrankheiten
EP2265643B1 (de) 2008-03-13 2016-10-19 Biotest AG Dosierungsschema zur behandlung von psoriasis und rheumatoider arthritis
RU2540013C2 (ru) 2008-03-13 2015-01-27 Биотест Аг Средство для лечения заболевания
WO2009149382A2 (en) * 2008-06-06 2009-12-10 Baylor Research Institute Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
WO2010009129A2 (en) * 2008-07-15 2010-01-21 Genentech, Inc. Methods of treating autoimmune diseases using cd4 antibodies
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease
CN120569191A (zh) 2022-11-23 2025-08-29 乔治亚大学研究基金公司 用于增加免疫应答的组合物及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies

Also Published As

Publication number Publication date
CA2055615A1 (en) 1990-12-13
ZA904174B (en) 1992-02-26
DD296843A5 (de) 1991-12-19
AU5725890A (en) 1991-01-07
WO1990015152A1 (en) 1990-12-13
IE901949L (en) 1990-11-30
GB8912497D0 (en) 1989-07-19
JPH04505919A (ja) 1992-10-15
DK0474691T3 (da) 1996-12-02
PT94214B (pt) 1997-03-31
DE69029134D1 (de) 1996-12-19
JP2763197B2 (ja) 1998-06-11
NZ233889A (en) 1997-06-24
IE80735B1 (en) 1998-12-30
PT94214A (pt) 1991-02-08
KR0183029B1 (ko) 1999-04-01
AU657255B2 (en) 1995-03-09
EP0474691B1 (de) 1996-11-13
ES2096588T3 (es) 1997-03-16
MY135673A (en) 2008-06-30
DE69029134T2 (de) 1997-03-06
EP0474691A1 (de) 1992-03-18
HU905134D0 (en) 1992-02-28
HUT61341A (en) 1992-12-28
IL94566A0 (en) 1991-03-10
CA2055615C (en) 2001-07-17

Similar Documents

Publication Publication Date Title
ATE145246T1 (de) Monoklonale antikörper zur induzierung von toleranz
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
DK101888A (da) Immunmodulerende midler og anvendelse af disse
DK282987D0 (da) Lagdelt immunoanalyseorgan til bestemmelse af et antigens tilstedevaerelse, og hvori der anvendes antistoffer beregnet til transport af partikler
MY107079A (en) Method of reducing immunoglobulin e responses
NZ305083A (en) Use of cd40 binding proteins (a cd40 ligand or monoclonal antibody that specifically binds to cd40) for stimulating a immune response
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
DE69014116D1 (de) Immunoassay zur bestimmung der bindungsspezifität eines monoklonalen antikörpers.
EP0585364A4 (de) Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78.
ATE2048T1 (de) Isolierung von hepatitis be-antigen.
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
Beernink et al. Proteins adhering to Escherichia coli after exposure to guinea-pig serum
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
FI914924A7 (fi) Monoklonaalinen vasta-aine suomusolukarsinooma-antigeenien erottamisee n ja menetelmä sen käyttämiseksi
DE69012572D1 (de) Monoklonaler antikörper gegen acetylierte lysinabfälle in rekombinantem rindsomatotropin.
DE69322960D1 (de) Empfängnisverhütender impfstoff
IT1254570B (it) Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione.
LV10202A (lv) Cilveka karcinomas asociets antigens un to saistosa antiviela

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time